Abstract
Fifty-two children with superficial skin and soft tissue infections were randomized to receive sultamicillin or cloxacillin for 7 days. Twenty-one children in each group finished the study. A total of 16 of 21 in the sultamicillin group and 13 of 21 in the cloxacillin group were cured. One child in the sultamicillin group and two in the cloxacillin group failed therapy. Four children who received sultamicillin and six who received cloxacillin had recurrences of lesions. Differences were not statistically significant.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aronoff S. C., Klinger J. D., O'Brien C. A., Jaffe A. C., Blumer J. L. A double-blinded comparative study of sultamicillin and potassium penicillin V in the treatment of childhood streptococcal pharyngitis. J Antimicrob Chemother. 1984 Sep;14(3):261–265. doi: 10.1093/jac/14.3.261. [DOI] [PubMed] [Google Scholar]
- BURNETT J. W. The route of antibiotic administration in superficial impetigo. N Engl J Med. 1963 Jan 10;268:72–75. doi: 10.1056/NEJM196301102680203. [DOI] [PubMed] [Google Scholar]
- DAJANI A. S., GARCIA R. E., WOLINSKY E. Etiology of cervical lymphadenitis in children. N Engl J Med. 1963 Jun 13;268:1329–1333. doi: 10.1056/NEJM196306132682403. [DOI] [PubMed] [Google Scholar]
- Esterly N. B., Markowitz M. The treatment of pyoderma in children. JAMA. 1970 Jun 8;212(10):1667–1670. [PubMed] [Google Scholar]
- Ginsburg C. M., McCracken G. H., Jr, Olsen K., Petruska M. Pharmacokinetics and bactericidal activity of sultamicillin in infants and children. J Antimicrob Chemother. 1985 Mar;15(3):345–351. doi: 10.1093/jac/15.3.345. [DOI] [PubMed] [Google Scholar]
- Kaleida P. H., Bluestone C. D., Blatter M. M., Reisinger K. S., Wucher F. P., Fall P. A., Rohn D. D. Sultamicillin (ampicillin-sulbactam) in the treatment of acute otitis media in children. Pediatr Infect Dis. 1986 Jan-Feb;5(1):33–38. doi: 10.1097/00006454-198601000-00007. [DOI] [PubMed] [Google Scholar]
- Kosmidis J., Stathakis C., Mantopoulos K., Pouriezi T., Papathanassiou B., Daikos G. K. Clinical pharmacology of cefotaxime including penetration into bile, sputum, bone and cerebrospinal fluid. J Antimicrob Chemother. 1980 Sep;6 (Suppl A):147–151. doi: 10.1093/jac/6.suppl_a.147. [DOI] [PubMed] [Google Scholar]